Logo image of NXU.DE

NEXUS AG (NXU.DE) Stock Price, Forecast & Analysis

Europe - Frankfurt Stock Exchange - FRA:NXU - DE0005220909 - Common Stock

71.2 EUR
-0.1 (-0.14%)
Last: 11/24/2025, 7:00:00 PM

NXU.DE Key Statistics, Chart & Performance

Key Statistics
Market Cap1.23B
Revenue(TTM)280.33M
Net Income(TTM)33.95M
Shares17.27M
Float650.00K
52 Week High74.3
52 Week Low67
Yearly Dividend0.22
Dividend Yield0.32%
EPS(TTM)1.97
PE36.14
Fwd PE32.24
Earnings (Next)03-02
IPO2000-07-24
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Technology
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Technology
NXU.DE short term performance overview.The bars show the price performance of NXU.DE in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 0.2 -0.2 -0.4 -0.6 -0.8

NXU.DE long term performance overview.The bars show the price performance of NXU.DE in the last 1, 2 and 3 years. 1 year 2 years 3 years 10 20 30

The current stock price of NXU.DE is 71.2 EUR. In the past month the price increased by 0.28%. In the past year, price increased by 4.09%.

NEXUS AG / NXU Daily stock chart

NXU.DE Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to NXU.DE. When comparing the yearly performance of all stocks, NXU.DE turns out to be only a medium performer in the overall market: it outperformed 44.11% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

NXU.DE Fundamental Analysis

ChartMill assigns a fundamental rating of 7 / 10 to NXU.DE. Both the health and profitability get an excellent rating, making NXU.DE a very profitable company, without any liquidiy or solvency issues.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NXU.DE Financial Highlights

Over the last trailing twelve months NXU.DE reported a non-GAAP Earnings per Share(EPS) of 1.97. The EPS increased by 26.97% compared to the year before.


Industry RankSector Rank
PM (TTM) 12.11%
ROA 6.93%
ROE 11.27%
Debt/Equity 0.05
Chartmill High Growth Momentum
EPS Q2Q%-3.19%
Sales Q2Q%9.14%
EPS 1Y (TTM)26.97%
Revenue 1Y (TTM)7.41%

NXU.DE Forecast & Estimates

7 analysts have analysed NXU.DE and the average price target is 71.4 EUR. This implies a price increase of 0.28% is expected in the next year compared to the current price of 71.2.

For the next year, analysts expect an EPS growth of 14.6% and a revenue growth 9.04% for NXU.DE


Analysts
Analysts45.71
Price Target71.4 (0.28%)
EPS Next Y14.6%
Revenue Next Year9.04%

NXU.DE Ownership

Ownership
Inst Owners21.55%
Ins OwnersN/A
Short Float %N/A
Short RatioN/A

NXU.DE Competitors/Peers

The largest stocks on the EU markets in the "Health Care Technology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
EQS.PA EQUASENS 17.02 619.69M
GPI.MI GPI SPA 20.77 450.42M
ALCGM.PA CEGEDIM SA N/A 193.88M
ALMDT.PA MEDIAN TECHNOLOGIES N/A 158.81M
AGFB.BR AGFA-GEVAERT NV N/A 78.34M
AJ91.DE DOCCHECK AG 12.6 66.42M
M3V.DE MEVIS MEDICAL SOLUTIONS AG 9.92 45.14M
ALINS.PA INTRASENSE SAS N/A 12.13M

Related stock screener links

About NXU.DE

Company Profile

NXU logo image NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,971 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.

Company Info

NEXUS AG

Irmastrasse 1

Donaueschingen BADEN-WUERTTEMBERG DE

Employees: 1909

NXU Company Website

NXU Investor Relations

Phone: 49771229600

NEXUS AG / NXU.DE FAQ

Can you describe the business of NEXUS AG?

NEXUS AG engages in the development and sale of software and hardware solutions. The company is headquartered in Donaueschingen, Baden-Wuerttemberg and currently employs 1,971 full-time employees. The company went IPO on 2000-07-24. The firm is engaged in the development, trade and service of software solutions for facilities of the healthcare system. The company is divided into three divisions: NEXUS/ DE (Germany), NEXUS/ DIS (Diagnostic systems) and NEXUS/ ROE (Rest of Europe). The firm has different product groups such as: NEXUS/ HISng, an information system for somatic hospitals in Germany; NEXUS/ PSYCHIATRY, an information system for psychiatric institutions; NEXUS/ REHAng, an information system for rehabilitation facilities; NEXUS/ ITR, a software for rehabilitation, private, acute care clinics not providing surgery and hotels with medical care; NEXUS/ ARCHIVE and NEXUS/ PEGASOS, provides archiving and process management in healthcare, among others.


What is the current price of NXU stock?

The current stock price of NXU.DE is 71.2 EUR. The price decreased by -0.14% in the last trading session.


What is the dividend status of NEXUS AG?

NEXUS AG (NXU.DE) has a dividend yield of 0.32%. The yearly dividend amount is currently 0.22.


What is the ChartMill technical and fundamental rating of NXU stock?

NXU.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.


What is NEXUS AG worth?

NEXUS AG (NXU.DE) has a market capitalization of 1.23B EUR. This makes NXU.DE a Small Cap stock.


What is the ownership structure of NEXUS AG (NXU.DE)?

You can find the ownership structure of NEXUS AG (NXU.DE) on the Ownership tab.